acute ocular pain epidemiology forecast

DelveInsight’s ‘Acute Ocular Pain (AOP)—Epidemiology Forecast–2034’ report delivers an in-depth understanding of the AOP, historical and forecasted epidemiology as well as the AOP trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan, China, and Canada.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan
• China
• Canada

Study Period: 2021-2034

Acute Ocular Pain (AOP) Disease Understanding

Eye pain is a myriad of symptoms ranging from a sharp pain in the eye to mild discomfort or itching in the eyes. As the spectrum of symptom presentation varies with eye pain, the cause of these pains may vary from straightforward refractive errors to potentially sight-threatening disorders like glaucoma and uveitis. A feeling of discomfort or pain in the eye can be caused by a problem in the eye itself. It can also be caused by a problem involving any structures around the eye or referred pain from tissues with similar innervation as ocular tissues (V1). Patients with eye pain or periorbital pain frequently present to primary care physicians, neurologists, or ophthalmologists.

Most ophthalmologic conditions producing ocular pains are associated with obvious ocular symptoms and signs like red-eye, photophobia, vision loss, or diplopia. Sometimes it poses a challenge to physicians when the pain is associated with a quiet eye or “white eye”.

Depending on where the patients experience the discomfort, eye pain can fall into one of two categories: Ocular pain occurring on the eye’s surface and orbital pain within the eye.

Eye pain that occurs on the surface may be scratching, burning, or itching sensation. Surface pain is usually caused by irritation from a foreign object, infection, or trauma. Often, this type of eye pain is easily treated with eye drops or rest.

Continued in the report…..

Acute Ocular Pain (AOP) Epidemiology Perspective by DelveInsight

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Cases of Several Eye Disorders, and Total Cases of Acute Ocular Pain (AOP) scenario in the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), Japan, China and Canada from 2021 to 2034.

Acute Ocular Pain (AOP) Detailed Epidemiology Segmentation

• In 2020, the total cases of Acute Ocular Pain (AOP) were 27,327,387 cases in the 7MM, Canada and China, which might increase by 2034.
• In 2020 the US accounted for 4,038,628 AOP cases, which is anticipated to increase by 2034.
• In 2020, the EU5 countries accounted for 4,527,206 cases., which is seen to increase by 2034.
• Among EU5 countries, Germany had the highest number of cases of Acute Ocular Pain (AOP), which were 1,109,517 cases in 2020. As per DelveInsight’s estimates, this count will increase through the study period.
• Japan, in 2020, accounted for 1,315,445 cases of AOP, which will increase by the year 2034.
• In 2020, there were 888,810 cases recorded for AOP in Canada which are estimated to increase during the study period.
• There were 16,557,297 cases recorded for AOP in China during 2020.

Scope of the Report

• The report covers the descriptive overview of AOP, explaining its causes, symptoms, pathophysiology, and other aspects.
• The report provides insight into the 7MM, China, and Canada historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan along with China and Canada.
• The report assesses the disease risk and burden and highlights the unmet needs of Acute Ocular Pain (AOP).
• The report helps to recognize the growth opportunities in the 7MM, China, and Canada with respect to the patient population.
• The report provides the segmentation of the disease epidemiology for 7MM, China, and Canada by Total Cases of Several Eye Disorders, and Total Cases of Acute Ocular Pain (AOP).

Report Highlights

• 10-Year Forecast of AOP
• 7MM, China, and Canada Coverage
• Total Cases of Several Eye Disorders
• Total Cases of Acute Ocular Pain (AOP)

Key Questions Answered

• What are the disease risk, and burden of AOP?
• What is the historical AOP patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK), Japan, China, and Canada?
• What would be the forecasted patient pool of AOP at the 7MM, China, and Canada level?
• What will be the growth opportunities across the 7MM, China, and Canada with respect to the patient population pertaining to AOP?
• Out of the above-mentioned countries, which country would have the highest prevalent population of AOP during the forecast period (2025-2034)?
• At what CAGR the population is expected to grow across the 7MM, China, and Canada during the forecast period (2025-2034)?

Reasons to buy

The Acute Ocular Pain (AOP) report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the 7MM, China, and Canada AOP epidemiology forecast.
• The AOP epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
• The AOP epidemiology model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the 10-year forecast period using reputable sources.

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population